ARCHIVES

Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects

This article is from The Cancer Letter archive.

Vol. 06 No. 25 | June 20, 1980

Download PDF Visit The Full Archive

Related Articles

Elderly Patients Fail To Receive New Cancer Therapy For CML

August 27, 2010

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

ORI takes Over Misconduct Inquiry Of NSABP Officials

July 29, 1994

Grant Supplements, and Challenge Grants

February 20, 2009

Preoperative Drug Combo Benefits HER-2 Breast Cancer

April 29, 2005